WallStreetZenWallStreetZen

NASDAQ: PYXS
Pyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?

Insider buying vs selling

Have Pyxis Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Pamela Ann ConnealyCFO and COO2023-11-2936,949$1.40
$51.73kSell
Pamela Ann ConnealyCFO and COO2023-09-288,000$1.87
$14.96kBuy
Pamela Ann ConnealyCFO and COO2023-09-276,426$1.85
$11.87kBuy
Jitendra WadhaneChief Accounting Officer2023-09-272,500$1.87
$4.68kBuy
Jitendra WadhaneChief Accounting Officer2023-09-255,000$1.77
$8.85kBuy
Pamela Ann ConnealyCFO and COO2023-09-2512,000$1.67
$20.04kBuy
Pamela Ann ConnealyCFO and COO2023-09-225,000$1.74
$8.70kBuy
Jitendra WadhaneChief Accounting Officer2023-09-222,500$1.74
$4.35kBuy
Lara SullivanPresident and CEO2023-09-188,541$2.10
$17.94kSell
Lara SullivanPresident and CEO2023-09-14100$2.25
$225.00Sell

1 of 2

PYXS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PYXS insiders and whales buy or sell their stock.

PYXS Shareholders

What type of owners hold Pyxis Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc12.10%7,032,770$29.54MInsider
Barclays PLC5.98%3,477,975$14.61MInsider
Laurion Capital Management LP5.45%3,170,803$13.32MInstitution
Bayer World Investments Bv4.72%2,742,338$11.52MInsider
Lara Sullivan4.14%2,403,882$10.10MInsider
Vanguard Group Inc2.25%1,306,685$5.49MInstitution
Cormorant Asset Management LP1.92%1,118,854$4.70MInsider
Pamela Ann Connealy1.91%1,110,293$4.66MInsider
Jay Feingold1.26%730,345$3.07MInsider
Abrdn PLC1.22%708,303$2.97MInstitution

1 of 3

PYXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYXS15.13%36.17%Net Selling
XBIT11.32%45.18%
QURE78.37%13.99%Net SellingNet Selling
ELEV53.13%24.22%Net SellingNet Selling
CDXS46.84%53.16%Net Buying

Pyxis Oncology Stock Ownership FAQ

Who owns Pyxis Oncology?

Pyxis Oncology (NASDAQ: PYXS) is owned by 15.13% institutional shareholders, 36.17% Pyxis Oncology insiders, and 48.69% retail investors. Pfizer Inc is the largest individual Pyxis Oncology shareholder, owning 7.03M shares representing 12.10% of the company. Pfizer Inc's Pyxis Oncology shares are currently valued at $29.96M.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.